Literature DB >> 28734619

Fibromyalgia: Prevalence, epidemiologic profiles and economic costs.

Asensi Cabo-Meseguer1, Germán Cerdá-Olmedo2, José Luis Trillo-Mata3.   

Abstract

Fibromyalgia is an idiopathic chronic condition that causes widespread musculoskeletal pain, hyperalgesia and allodynia. This review aims to approach the general epidemiology of fibromyalgia according to the most recent published studies, identifying the general worldwide prevalence of the disease, its basic epidemiological profiles and its economic costs, with specific interest in the Spanish and Comunidad Valenciana cases. Fibromyalgia affects, on average, 2.10% of the world's population; 2.31% of the European population; 2.40% of the Spanish population; and 3.69% of the population in the Comunidad Valenciana. It supposes a painful loss of the quality of life of the people who suffer it and the economic costs are enormous: in Spain is has been estimated at more than 12,993 million euros annually.
Copyright © 2017 Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Economic impact; Epidemiology; Epidemiología; Fibromialgia; Fibromyalgia; Impacto económico; Prevalence; Prevalencia

Mesh:

Year:  2017        PMID: 28734619     DOI: 10.1016/j.medcli.2017.06.008

Source DB:  PubMed          Journal:  Med Clin (Barc)        ISSN: 0025-7753            Impact factor:   1.725


  34 in total

Review 1.  Milnacipran for the Treatment of Fibromyalgia.

Authors:  Harshit Gupta; Brook Girma; Jack S Jenkins; Sarah E Kaufman; Christopher A Lee; Alan D Kaye
Journal:  Health Psychol Res       Date:  2021-07-10

2.  Can the Combination of Rehabilitation and Vitamin D Supplementation Improve Fibromyalgia Symptoms at All Ages?

Authors:  Dalila Scaturro; Fabio Vitagliani; Sofia Tomasello; Mirko Filippetti; Alessandro Picelli; Nicola Smania; Giulia Letizia Mauro
Journal:  J Funct Morphol Kinesiol       Date:  2022-06-20

Review 3.  Co-occurrence of pain syndromes.

Authors:  Giannapia Affaitati; Raffaele Costantini; Claudio Tana; Francesco Cipollone; Maria Adele Giamberardino
Journal:  J Neural Transm (Vienna)       Date:  2019-11-29       Impact factor: 3.575

4.  How good is online information on fibromyalgia? An analysis of quality and readability of websites on fibromyalgia in Spanish.

Authors:  Arturo Alioshkin Cheneguin; Isabel Salvat Salvat; Helena Romay Barrero; María Torres Lacomba
Journal:  BMJ Open       Date:  2020-07-05       Impact factor: 2.692

Review 5.  Diagnostic Criteria for Fibromyalgia: Critical Review and Future Perspectives.

Authors:  Carmen M Galvez-Sánchez; Gustavo A Reyes Del Paso
Journal:  J Clin Med       Date:  2020-04-23       Impact factor: 4.241

6.  Quality of life related to foot health status in women with fibromyalgia: a case-control study.

Authors:  Patricia Palomo-López; César Calvo-Lobo; Ricardo Becerro-de-Bengoa-Vallejo; Marta Elena Losa-Iglesias; David Rodriguez-Sanz; Rubén Sánchez-Gómez; Daniel López-López
Journal:  Arch Med Sci       Date:  2018-07-10       Impact factor: 3.318

7.  Metacognitions on Pain, Functionality and Intensity of Pain in Women with Fibromyalgia.

Authors:  Misleydis Ortega-González; Daniel-Camilo Aguirre-Acevedo; Mercedes Jiménez-Benítez
Journal:  Int J Psychol Res (Medellin)       Date:  2021 Jan-Jun

8.  Women with Fibromyalgia Prefer Resistance Exercise with Heavy Loads-A Randomized Crossover Pilot Study.

Authors:  Ulf Mathias Andersson; Anna Cristina Åberg; Lena von Koch; Annie Palstam
Journal:  Int J Environ Res Public Health       Date:  2021-06-10       Impact factor: 3.390

9.  The effect of cryotherapy on fibromyalgia: a randomised clinical trial carried out in a cryosauna cabin.

Authors:  Javier Rivera; María José Tercero; Javier Salas Salas; Julio Hernández Gimeno; Javier Sánchez Alejo
Journal:  Rheumatol Int       Date:  2018-10-23       Impact factor: 2.631

10.  Serum levels of serotonin as a biomarker of newly diagnosed fibromyalgia in women: Its relation to the platelet indices.

Authors:  Marwan S M Al-Nimer; Talar A Merza Mohammad; Riyadh A Alsakeni
Journal:  J Res Med Sci       Date:  2018-08-23       Impact factor: 1.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.